TitleAuthorsJournal & DateDOI & Link
Action needed to address HbA1C and weight increases in people initiating antipsychotic medicinesHynes-Ryan C, Carolan A, Keating D, O'Donoghue BLancet Psychiatry

November 2026
https://doi.org/10.1016/S2215-0366(26)00307-X
Olanzapine Dosing in Women with First-Episode Psychosis: An Age-Based Proxy for Menopausal StatusBurke T, O'Connor K, Sommer IE, Keating D, Duffy, R, Doherty A, O'Donoghue BSchizophrenia Bulletin

24 August 2026
https://doi.org/10.1093/schbul/sbag156
Management of clozapine-resistant schizophreniaLally J, Gee S, Hynes-Ryan C, Northwood K, Keating D, Suetani S, Siskind D,
O'Donoghue B
Australian and New Zealand Journal of Psychiatry

19 July 2026
https://doi.org/10.1177/00048674261462755
Clinical
Practice Guideline on the Pharmacological Management of Antipsychotic-Related
Dyslipidemia
Carolan A, Hynes-Ryan C, Bourke R, Columb D, Cullen W, deFerranti S,
Harrington SM, Kelleher I, Kennedy C, Khoury M, Lally J, Lyne J, Norton M,
O'Connor K, O'Connor P, O'Shea D, Perry B, Prendeville T, Ryan C, Sadowska E,
Shiers D, Siskind D, Strawbridge J, Tae H, Keating D, O'Donoghue B
Schizophrenia Bulletin

3 July 2026
https://doi.org/10.1093/schbul/sbag086
Is a higher antipsychotic dose required to treat relapse in remitted first episode psychosis? A systematic review and meta-analysisTeague V, Guilfoyle S, Pocha P, Paneer Chelvam T, Lally J, O'Donoghue BSchizophrenia Research

15 June 2026
https://doi.org/10.1016/j.schres.2026.06.006
Identifying Clinical Characteristics of Young People with Treatment-Resistant Schizophrenia Undergoing Community Initiation of ClozapineConaty O, Thompson A, McGorry P, Gaughran F, O'Donoghue B, Lally JSchizophrenia Bulletin

3 May 2026
https://doi.org/10.1093/schbul/sbag071
Proportion and Reasons for Clozapine Discontinuation: A Systematic Review and Meta-AnalysisMcLaughlin P, McManus R, Conaty O, Al-Harbi F, Gaughran F, O’ Donoghue B, Lally JSchizophrenia Bulletin Open

30 April 2026
https://doi.org/10.1093/schizbullopen/sgag016
Co-design of antipsychotic medication information resources - making PROGRESS in shared decision makingHynes-Ryan C, Carolan A, Norton MJ, Cussen S, McWilliams S, Renwick L, O'Donoghue B, Keating DIrish Journal of Psychological Medicine

22 April 2026
https://doi.org/10.1017/ipm.2026.10193
Treatment of lithium-induced side-effects: Contemporary reviewNieuwoudt W, Maher C, O’Donoghue B, Lally JThe British Journal of Psychiatric Advances

23 March 2026
https://doi.org/10.1192/bja.2026.10203
The duration of active psychosis and relationship with early psychosis outcomesCrowley P, Boland F, Thompson A, McGorry P, O’Donoghue B, Lyne JSchizophrenia Research

18 March 2026
https://doi.org/10.1016/j.schres.2026.03.014
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of PsychosisHynes-Ryan C, Keating D, Carolan A, Brand B, Dazzan P, Gaughran F, Hahn M, Halstead S, Harrington SM, Hartnett Y, Kelleher I, Lyne J, McNicholas F, O’Connor K, Perry B, Sadowska E, O’Donoghue B, Sommer IESchizophrenia Bulletin

7 March 2026
https://doi.org/10.1093/schbul/sbag023
Pharmacological interventions to manage cardiometabolic outcomes in adults with severe mental illness: Umbrella reviewCarolan A, Keating D, Marmion A, Coady A, Ryan IJ, Hynes-Ryan C, O’Donoghue
B, Strawbridge JD, Ryan C
The British Journal of Psychiatry

4 December 2025
https://doi.org/10.1192/bjp.2025.10476
Metformin:
translating the evidence for prevention of weight gain
Carolan A, Hynes-Ryan C, O’Shea D, Keating D, O’Donoghue BLancet Psychiatry

December 2025
https://doi.org/10.1016/S2215-0366(25)00309-8
A Scoping Review of Methods, Guidelines, and Protocols
Used for Dose Reduction or Discontinuation of Antipsychotic Medication in People
Affected by Psychotic Disorders
Jeffares I, Friars D, Plapp H, Allott K, Cadogan C, Keating D, Mooney C,
O’Connor K, O’Donoghue B
Schizophrenia Bulletin

28 October 2025
https://doi.org/10.1093/schbul/sbaf181
Duration of active psychosis: A scoping review of definition, measurement and relationship with outcomesCrowley P, Healy J, McNamara N, Twomey R, Sadowska E, Firth J, Allott K, Shah
J, O’Donoghue B, Lyne J
Schizophrenia Research

8 October 2025
https://doi.org/10.1016/j.schres.2025.09.032
Fighting fire with fire: the need to use metformin to combat antipsychotic-
induced weight gain and metabolic complications
Carrington FA, Keating D, Norton MJ, Lyne JP, Siskind D, O’Shea D, O’Donoghue
B
Irish Journal of Psychological Medicine

13 August 2025
https://doi.org/10.1017/ipm.2025.10084
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationCarolan A, Hynes-Ryan C, Agarwal SM, Bourke R, Cullen W, Gaughran F, Hahn MK, Krivoy A, Lally J, Leucht S, Lyne J, McCutcheon RA, Norton MJ, O'Connor K, Perry BI, Pillinger T, Shiers D, Siskind D, Thompson A, O'Shea D, Keating D, O'Donoghue BSchizophrenia Bulletin

9 December 2024
https://doi.org/10.1093/schbul/sbae205
Psychiatrists' views on clozapine prescribing in IrelandGrant A, McManus R, Belay H, Mahon M, Murad F, O’ Donoghue B, Lally JIrish Journal of Psychological Medicine

2 October 2024
https://doi.org/10.1017/ipm.2024.35